文献速递其他结缔组织病

系统性硬化症重叠肌炎患者的结局:倾向评分匹配队列研究

Outcomes of systemic sclerosis with overlapping myositis: a propensity score-matched cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2026-10-16

该单中心回顾性队列研究纳入880例系统性硬化症(SSc)患者,其中92例(10.4%)合并肌炎,经1:1倾向评分匹配后分析92对。肌炎独立预测心脏受累(标准aOR=19.99,95%CI 2.19-182.26,p=0.008),但总死亡率无差异(13.0% vs 9.8%,p=0.620);非肌炎组死亡中ILD占33.3%,肌炎组死亡中心力衰竭占25%且无ILD相关死亡。

要点

  • SSc重叠肌炎独立增加心脏受累风险,标准aOR=19.99(95%CI 2.19-182.26)。
  • mRSS每增加10分亦预测心脏受累(aOR=2.34,p=0.006)。
  • 总死亡率无差异,但肌炎组死亡原因转向心力衰竭而非ILD。

核心结论

  • SSc重叠肌炎与心脏受累风险增加相关,并使死亡原因从ILD转向心脏衰竭,但总生存无差异。

研究设计与样本

  • 单中心回顾性队列研究,纳入880例符合2013 ACR/EULAR标准的SSc患者,按1:1倾向评分匹配后分析92对(n=184)。

主要发现

  • 880例中92例(10.4%)合并肌炎;匹配后肌炎独立预测心脏受累(标准aOR=19.99,95%CI 2.19-182.26,p=0.008;Firth OR=12.84,95%CI 2.31-98.47,p=0.006)。
  • mRSS每增加10分预测心脏受累(aOR=2.34,p=0.006);抗Scl70在肌炎组较少见(25.0% vs 50.0%,p=0.009)。
  • 总死亡率无差异(13.0% vs 9.8%,p=0.620);非肌炎组死亡中ILD占33.3%,肌炎组死亡中心力衰竭占25%且无ILD相关死亡(Fisher p=0.229)。
  • 心脏受累与死亡率显著相关(aHR=8.09,95%CI 1.36-48.26,p=0.022),独立于肌炎。

关键数值与推荐

  • SSc肌炎定义为近端肌无力伴肌酶升高且无其他原因。
  • 心脏受累采用SCTC标准(心包积液、心室功能障碍、心律失常、传导疾病)。

临床怎么用

  • 对SSc重叠肌炎患者应进行系统性心脏监测。

局限性

  • 单中心回顾性设计,中位随访21个月,事件数较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc) carries the highest disease-specific mortality among rheumatic diseases, with cardiac involvement and interstitial lung disease (ILD) as leading causes of death. We aimed to determine whether overlapping myositis independently contributes to cardiac involvement and mortality in SSc. METHODS: We did a 1:1 propensity score matched retrospective cohort study of 880 SSc patients (2013 ACR/EULAR criteria) at a single centre. SSc myositis required proximal weakness and elevated muscle enzymes without alternative causes. Cardiac involvement used SCTC criteria (pericardial effusion, ventricular dysfunction, arrhythmia, conduction disease). We used standard and Firth penalised logistic regression for cardiac predictors, Cox regression for survival, and Fisher's exact test for cause specific mortality. All p values were Benjamini-Hochberg adjusted. RESULTS: Of 880 patients, 92 (10.4%) had myositis. After matching, 92 pairs (n = 184) were analysed. Myositis independently predicted cardiac involvement (standard aOR=19.99, 95%CI 2.19-182.26, p = 0.008; Firth OR = 12.84, 95%CI 2.31-98.47, p = 0.006). Higher mRSS also predicted cardiac involvement (aOR=2.34 per 10 points, p = 0.006). Anti-Scl70 was less common in myositis (25.0% vs. 50.0%, p = 0.009). Overall mortality did not differ (13.0% vs. 9.8%, p = 0.620). In non-myositis deaths, ILD caused 33.3%; in myositis deaths, cardiac failure caused 25% and no ILD-related deaths (Fisher's p = 0.229). Cardiac involvement was significantly associated with mortality (aHR=8.09 (1.36-48.26), p = 0.022), independent of myositis. CONCLUSION: Overlapping myositis in SSc is associated with an increased risk of cardiac involvement and a shift in the cause-of-death profile away from ILD, without a detectable difference in overall survival over the observed median 21-month follow-up. Systematic cardiac surveillance is needed in these patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Minikumari Rahulan L, Gowda Av N, Gollarahalli Patel A, et al. Outcomes of systemic sclerosis with overlapping myositis: a propensity score-matched cohort study. Rheumatology (Oxford). 2026. PMID: 42886520. doi:10.1093/rheumatology/keag578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。